olmesartan has been researched along with Glaucoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mittag, TW; Podos, SM; Wang, RF; Yokoyoma, T | 1 |
Iseki, K; Ito, N; Kikuchi, T; Kusai, A; Sasaki, H; Suzuki, M | 1 |
2 other study(ies) available for olmesartan and Glaucoma
Article | Year |
---|---|
Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes.
Topics: Administration, Topical; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glaucoma; Imidazoles; Intraocular Pressure; Lasers; Macaca fascicularis; Models, Animal; Receptor, Angiotensin, Type 1; Tetrazoles; Tonometry, Ocular | 2005 |
Self-association properties of 4-[1-hydroxy-1-methylethyl]-2-propyl-1-[4-[2-[tetrazole-5-yl]phenyl]phenyl] methylimidazole-5-carboxylic acid monohydrate (CS-088), an antiglaucoma ophthalmic agent.
Topics: 1-Propanol; Dimerization; Glaucoma; Imidazoles; Magnetic Resonance Spectroscopy; Micelles; Molecular Weight; Ophthalmic Solutions; Particle Size; Sodium Chloride; Spectrophotometry; Surface Tension; Tetrazoles; Urea | 2005 |